Tyrosine Kinase Inhibitors’ Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer

Tyrosine kinase inhibitors (TKIs) have been used in the treatment of multiple types of cancer. Pazopanib is one of the TKIs and is considered a first-line treatment for adult patients with metastatic renal cell carcinoma. Many endocrine-related adverse effects have been noted with the use of TKIs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshimy, Ghada, Gandhi, Anand, Guo, Rong, Correa, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339903/
https://www.ncbi.nlm.nih.gov/pubmed/32583692
http://dx.doi.org/10.1177/2324709620936808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339903/
https://www.ncbi.nlm.nih.gov/pubmed/32583692
http://dx.doi.org/10.1177/2324709620936808

Ejemplares similares